Armando E. Giuliano, MD

Professor of Surgery, Director Division of Surgical Oncology
Cedars-Sinai Medical Center

Poster(s):

• E21: Axillary Lymph Node Dissection Should Not Be Avoided in Patients Who Undergo Neoadjuvant Chemotherapy for a Positive Sentinel Node after Targeted Axillary Staging

• E53: Local Recurrence Among Patients Treated with Nipple Sparing Mastectomy After Neoadjuvant Chemotherapy

• E6: Comparison of Targeted Axillary Dissection versus Sentinel Node Biopsy Alone on Nodal Recurrence for Patients with Node-Positive Breast Cancer treated with Neoadjuvant Chemotherapy